Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine Effect on Inhibitory Control in Parkinson's
NCT03665493Completed
- Start
- Sep 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levodopa in Parkinson's disease (PD) (5 arms). Primary endpoints: Stop Signal Reaction Time, Reaction Time and 1 more. Started Sep 2020; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03665493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665493.